Stay updated on Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The website footer now identifies the site as revision v3.8.1 instead of v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-18T02:39:07.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The study record for the daratumumab Phase II trial is available, with details on its design, participant eligibility, treatment, locations, outcome measures, and results. It also includes a study protocol and statistical analysis plan.
    Difference
    53%
    Check dated 2026-11-11T01:48:58.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-11-04T00:05:48.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A banner announces an NIH terminology transition, and the site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:07:38.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The footer’s software revision changed from v3.7.0 to v3.7.1; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T00:25:00.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the study record content with a generic error page. This indicates an access restriction rather than changes to the study data.
    Difference
    19%
    Check dated 2026-09-23T01:25:39.000Z thumbnail image

Stay in the know with updates to Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in High-Risk MGUS & Low-Risk Smoldering Clinical Trial page.